Tominaga, Yoshiko
Aomori, Tohru
Hayakawa, Tomohisa
Kijima, Nobuhiko
Morisky, Donald E.
Takahashi, Kunihiko
Mochizuki, Mayumi
Article History
Received: 28 December 2017
Accepted: 1 June 2018
First Online: 3 July 2018
Ethics approval and consent to participate
: The Ethics and Research Board of the Faculty of Pharmacy, Keio University, approved this study protocol (approval nos. 161215–1 and 170120–1). The study objective and methods were explained to the participants using written documents to obtain their signed consent after confirming their sufficient understanding and agreement.
: DEM is the developer/owner of the copyrighted MMAS diagnosed adherence assessment instrument and receives royalities. He was not involved in the data analysis. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.